SYDRA Biotech

Longevity drugs exist

SYDRA is to discover them ALL

Combining AI with in vivo screening to reveal the next generation of geroprotectors

Who we are?

At SYDRA [saɪdrə] we are unlocking secrets of prolonged health and lifespan.

Utilizing a state-of-the-art closed loop discovery platform, SYDRA blends advanced Artificial Neural Networks (ANN) with an autonomous robotic in vivo screening approach to identify novel small molecules with geroprotective properties.

Why SYDRA?

Domains synergy and closed loop discovery

SYDRA’s team being led by CSO with vivid vision in biogerontology future. Thrilled to skyrocket life quality and lifespan expectancy by combating hallmarks of aging.

An enthusiastic professor in ML, who bottom up tailored and trained AI models, including generative AI, for drug discovery. In SYDRA, AI leverages drug finding to a novel level, simultaneously sublimating capacity and dramatically reducing development time.

Passionate engineering lead creates robotic assistant, revolutionizes live screening, slashes costs. Advanced programming boosts speed, quality, crucial for scaling geroprotectors testing.